Last $45.71 USD
Change Today +0.85 / 1.89%
Volume 3.6M
PKI On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

perkinelmer inc (PKI) Snapshot

Open
$45.58
Previous Close
$44.86
Day High
$47.24
Day Low
$45.46
52 Week High
07/3/14 - $48.26
52 Week Low
10/15/14 - $38.96
Market Cap
5.2B
Average Volume 10 Days
1.3M
EPS TTM
$2.04
Shares Outstanding
113.0M
EX-Date
04/15/15
P/E TM
22.5x
Dividend
$0.28
Dividend Yield
0.61%
Current Stock Chart for PERKINELMER INC (PKI)

perkinelmer inc (PKI) Related Businessweek News

No Related Businessweek News Found

perkinelmer inc (PKI) Details

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, and to accelerates the discovery and development of critical new therapies. This segment provides early detection for genetic disorders from pre-conception to early childhood, as well as offers digital x-ray flat panel detectors and infectious disease testing for the diagnostics market; and a suite of solutions, such as reagents, liquid handling, and detection and imaging technologies that enable researchers to improve the drug discovery process. Its research portfolio includes instrumentation for automation and detection solutions, in vitro and in vivo imaging and analysis hardware and software, and a portfolio of consumable products, including drug discovery and research reagents. The Environmental Health segment provides services and solutions to facilitate the creation of safer food and consumer products, secure surroundings, and efficient energy resources. This segment offers analytical technologies, solutions, and services that enable its customers to understand the health aspects of environment, including air, water, soil, and food; analytical instrumentation for the industrial market that comprise the chemical, petrochemical, lubricant, electronics, semiconductor, and quality assurance industries; and laboratory services. The company markets its products and services under various brands directly through its own sales force. Its customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.

perkinelmer inc (PKI) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $978.3K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $469.6K
Senior Vice President and President of Human ...
Total Annual Compensation: $341.0K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $394.6K
Compensation as of Fiscal Year 2013.

perkinelmer inc (PKI) Key Developments

PerkinElmer Inc. Announces Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 28, 2014; Provides Earnings Guidance for the First Quarter of 2015 and Full Year 2015

PerkinElmer Inc. announced consolidated earnings results for the fourth quarter and full year ended December 28, 2014. For the quarter, the company reported revenue of $608,390,000 compared to $591,870,000 a year ago. Operating income from continuing operations was $30,567,000 compared to $92,930,000 a year ago. Income from continuing operations, before income taxes was $20,647,000 compared to $66,065,000 a year ago. Income from continuing operations was $31,314,000 or $0.28 per share compared to $73,455,000 or $0.65 per share a year ago. Net income was $30,787,000 or $0.27 per share compared to $66,873,000 or $0.59 per share a year ago. Adjusted EPS was $0.85 per share compared to $0.74 per share a year ago. Net cash provided by operating activities was $96,564,000 compared to $71,703,000 a year ago. Capital expenditures were $6,858,000 compared to $7,427,000 a year ago. Adjusted operating income was $130.6 million compared to $115.5 million a year ago. Operating cash flow from continuing operations was $282 million versus $157 million in 2013. Improved working capital efficiency and completed operational investments were key drivers to this significant level of improvement. Free cash flow for the fourth quarter was $90 million. For the full year, the company reported revenue of $2,237,219,000 compared to $2,157,586,000 a year ago. Operating income from continuing operations was $210,742,000 compared to $227,794,000 a year ago. Income from continuing operations, before income taxes was $169,603,000 compared to $163,684,000 a year ago. Income from continuing operations was $161,166,000 or $1.42 per share compared to $174,267,000 or $1.54 per share a year ago. Net income was $157,778,000 or $1.39 per share compared to $167,212,000 or $1.47 per share a year ago. Adjusted EPS was $2.47 per share compared to $2.10 per share a year ago. Net cash provided by operating activities was $281,597,000 compared to $158,591,000 a year ago. Capital expenditures were $29,072,000 compared to $38,981,000 a year ago. Adjusted operating income was $394.6 million compared to $347.2 million a year ago. For the full year 2015, the company forecasts GAAP earnings per share from continuing operations in the range of $2.04 to $2.10 and on a non-GAAP basis, which is expected to include the adjustments noted in the attached reconciliation, adjusted earnings per share of $2.58 to $2.64. The guidance assumes that the stronger US dollar will negatively impact earnings per share for 2015 by approximately $0.15. The company expects revenue of $2.28 billion to $2.32 billion. The company expects adjusted gross margin expansion of approximately 20 to 30 basis points and adjusted operating margin expansion of 30 to 50 basis points. Net interest expense is expected to be approximately $42 million to $44 million and adjusted tax rate is expected to be 21%. For the first quarter of 2015, the company is forecasting reported revenues to be in the range of $530 million to $540 million or essentially flat that represent organic revenue growth of 3% to 4%. Adjusted earnings per share expects to be in the range of $0.44 to $0.46.

PerkinElmer, Inc. Declares Regular Quarterly Dividend, Payable on May 11, 2015

The Board of Directors of PerkinElmer Inc. declared a regular quarterly dividend of $0.07 per share of common stock on January 23, 2015. This dividend is payable on May 11, 2015 to all shareholders of record at the close of business on April 17, 2015.

PerkinElmer Opens Suzhou PerkinElmer Medical Laboratory Co., Ltd. in China

PerkinElmer Inc. has opened Suzhou PerkinElmer Medical Laboratory Co. Ltd. in China. This new facility provides a comprehensive offering of lab services to hospitals and patients in China, supporting the prevention of birth defects in newborns and infectious disease in adults. The Suzhou PerkinElmer Medical Laboratory extends the Company's solutions to include an expanded range of lab services for customers and patients, including molecular cytogenetics detection, screening for inherited metabolic diseases (IMDs), and viral loads testing. The Suzhou PerkinElmer Medical Laboratory also serves as a venue for academics and clinical medical doctors to perform scientific R&D, collaborate and train colleagues, and transform medical research into the development of new technologies for clinical use. In addition, PerkinElmer plans to expand its menu of services in the lab to include a series of tumor testing, as well as introduce new applications based on molecular cytogenetic platforms such as sequencing technology.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PKI:US $45.71 USD +0.85

PKI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Getinge AB kr204.30 SEK -1.00
QIAGEN NV €20.31 EUR -0.25
Sirona Dental Systems Inc $90.22 USD -2.07
STERIS Corp $65.22 USD -1.27
Teleflex Inc $109.56 USD -2.31
View Industry Companies
 

Industry Analysis

PKI

Industry Average

Valuation PKI Industry Range
Price/Earnings 32.3x
Price/Sales 2.3x
Price/Book 2.5x
Price/Cash Flow 32.7x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PERKINELMER INC, please visit www.perkinelmer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.